Transient complement inhibition plus T-cell immunosuppression induces long-term survival of mouse-to-rat cardiac xenografts

Transplantation

Volumn 65, Issue 9, 1998, Pages 1210-1215

  Koyamada, Nozomi ^a,b   Miyatake, Tsukasa ^a,c   Candinas, Daniel ^a,d   Mark, Walter ^a,e   Hechenleitner, Paul ^a,e   Hancock, Wayne W ^a,f   Soares, Miguel P ^a   Bach, Fritz H ^a,g  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^f MILLENNIUM PHARMACEUTICALS INC   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBROTOXIN; CYCLOSPORIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPLEMENT DEPOSITION; COMPLEMENT INHIBITION; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOMODULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; VASCULAR ENDOTHELIUM; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, HETEROPHILE; COMPLEMENT INACTIVATOR PROTEINS; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSION; MALE; MICE; MICE, INBRED BALB C; MYOCARDIUM; RATS; RATS, INBRED LEW; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032525061     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199805150-00012     Document Type: Article

References (20)

1. Sawyer GJ, Gustafsson K, Fabre JW. Vascularized mouse-to-rat heart grafts: an unexpectedly difficult model of xenotransplantation. Transplant Proc 1995; 27: 309.
2. Gannedahl G, Fellstrom B, Larsson E, et al. Characteristics of mouse to rat xenograft heart transplantation. Eur Surg Res 1990; 22: 206.
3. Gannedahl G, Karlsson-Parra A, Wallgren AC, et al. Role of antibody synthesis and C activation in concordant xenograft retransplantation. Transplantation 1994; 58: 337.
4. Makowka L, Chapman FA, Cramer DV, Qian SG, Sun H, Starzl TE. Platelet-activating factor and hyperacute rejection: the effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts. Transplantation 1990; 50: 359.
5. Araneda D, Moon S, Pittman K, Thomas F. Considerations of the validity of mouse-to-rat xenograft combinations in xenograft testing. Transplant Proc 1994; 26: 1228.
6. Valdivia LA, Sun H, Rao AS, et al. Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplantation model. Transplant Proc 1996; 28: 733.
7. Hasan R, Vandenbogaerde JB, Wallwork J, White DJG. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production. Transplantation 1992; 54: 408.
8. Bach FH, Ferran C, Mark W, et al. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997; 3: 196.
9. Hechenleitner P, Mark W, Candinas D, et al. Protective genes expressed in endothelial cells of second hamster heart transplants to rats carrying an accommodated first graft. Xenotransplantation 1996; 3: 279.
10. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
11. Blakely ML, van der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58: 1059.
12. Mayer MM. Complement and complement fixation. In: Kabat K, Mayer MM, eds. Experimental immunochemistry. Springfield, IL: Thomas, 1961: 113.
13. Pan E, Valdivia LA, Tsugita M, et al. FK 506 proongs survival of liver but not heart mouse-to-rat vasculized xenografts. Transplant Proc 1994; 26: 1211.
14. Winkler H, Ferran C, Bach FH. Accommodation of xenografts: a concept revisited. Xenotransplantation 1995; 2: 53.
15. Platt JL. A perspective on xenograft rejection and accommodation. Immunol Rev 1994; 141: 5.
16. Cooper JT, Stroka DM, Brostjan C, et al. A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol. Chem 1996; 271: 18068
17. Read MA, Whitley MZ, Williams AJ, Collins T. NF-κB and IκBa: an inducible regulatory system in endothelial activation. J Exp Med 1994; 179: 503.
18. Willis D, Moore AR, Frederick R, Willoughby DA. Heme oxygenase: a novel target for immunomodulation of the inflammatory response. Nature Med 1996; 2: 87.
19. Miyatake T, Sato K, Takigami K, et al. Complement fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection. J Immunol (in press).
20. Dalmasso AP, He T, Benson BA. Human IgM xenoreactive natural antibodies can induce resistance of porcine endothelial cells to complement-mediated injury. Xenotransplantation 1996; 3: 54.